Autosomal Dominant Flashcards

week 6 (40 cards)

1
Q

expression

A

Severity or mildness of phenotype

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is expression influenced by?

A

environmental factors and allelic variants in other genes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Penetrance

A

Chance that an individual will actully develop symptoms

Partial = alleles manifest a phenotype in some

Full = 100% chance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the 4 types of mutated allele classifications (in terms of functional affect)

A

Hylomorphic – produces protein with reduced activity

Neuromorphic – produces protein with new activity or product

Antimorphic – antagonizes the activity of normal gene product

Hypermorphic- produces protein with increased activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Features of autosomal dominant inheritance

A

Vertical degree pattern

Multiple generations affected

Each person normally has an affected parent

Male and females equally affected

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Chances of affected child for:

Hetero disease x hetero disease =

Homo disease x homo health =

Hetero disease x homo healthy =

A

75%

100%

50%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Expression repeat disorders

A

Dynamic mutation in which there is an increase in the number of repeats in a tri DNA seq.

Causes improper protein function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How does slipping and miss paring in DNA replication = increase in repeats

A
  • backwards slippage
  • repeat expansion = hairpin
  • hairpin repeats incorporated
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What does Knudsib’s two-hit hypothesis propose about how diseases are inherited?

A

Familial = inherit a mutation, 2nd develops somatically

Sporadic = 2 somatic mutations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Rationale and testing strategy for pre-symptomatic testing.

A

Test affected family member for specific mutation

Confirm diagnosis of family member at risk ( if treatment is avalaible)

Offer pre-symptomatic testing or asses risk for recurrence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Why is gene therapy better for recessive traits? How can it be used in AD?

A

replaces nonfunctioning genes with a correct function

for AD = antisense RNA inhibition of gene expression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

explain the use of gene therapy for AD diseases.

A
  1. start with antisense siRNA complementary to an mRNA target region
  2. siRNA foms a complex that recognises target region
  3. target region is cleaved
  4. loss of protein synthesis (loss of function)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the gene affected in Achondroplasia and Hypochondroplasia and what is the normal function of it?

A

FGFR3

codes for a tyrosine kinase receptor that signals growth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the common cause of the muation in achondroplasia and hypocondroplasia?

A

De novo during embryogenesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the effect of achondroplasia and hypochondraplasia on cell function?

A
  • gain of function
    -inhibition of proliferation and hypertrophy of chondrocytes on growth plate
    -decreased echnodnral classification
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Reproductive expression of disease for Herero vs homo parents with achondropalsia.

A

If 2 hetero reproduce:
-2/3 dwarfism
1/3 normal

Homozygosity of mutant = incompatible of life.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

clinical features of Achondroplasia

A

Abnormal bone growth
Short stature
Large head
disproportionate limb trunks

18
Q

With achondroplasia, why is there is an increased risk of death in infancy?

A

spinal cord compression/ upper airway obstruction (bone does not grow wide enough)

19
Q

Affected gene, mutation and impact on cell level for hypochondroplasia

A

Gene
FGFR3

Mutations
p.ANS540Lys
p.Lys650Met

Gain of function –> decreased endochondral ossification, inhibited chondrocyte proliferation in growth plate and decerased cartlidge matrix production

LESS SEVERE

20
Q

Clinical features of hypochodroplasia

A

Normal birth and weigth

Disproportionate limb trunk length

Presents as toddlers

Short stature disproportionate to limbs as age

21
Q

Achondroplasia vs hypochondrial clinical presentations.

A

Hypo= NO trident hands or facail features

Hypo = normal motor milestones

22
Q

Affected gene, mutation and effect on phenotype for Huntingtion’s disease.

A

Gene
-HTT gene
Mutation
-CAG repeat in HTT protein
Phenotype
-HTT protein aggregation on cells = atrophy

23
Q

Huntington’s disease clinical features

A

Progressive motor disability

Chorea (jerky involuntary movements)

Cognitive decline

Mental disturbance

Changes in personality

onset depends on number of repeats
Adult onset = 40-55 repeats

Juvenile onset = greater than 60 repeats

24
Q

Penetrance of Huntington’s

A

need more than 40 repeats for be 100%

24
How many repeats of CAG in a person with vs without Huntington's disease?
Normal person = 10-26 Affected= 36-121
25
Anticipation
phenomenon in which there is increase disease severity and/ or earlier age of onset in successive generations
26
Treatment of HD.
None Potential for gene therapy
27
What are the three phenotypes of mytonic dystrophy and what determines their expression?
3 phenotypic affects -mild -classic -congineital Changes from M-C depending on increasing CTG repeats, decreased age of onset and decreased life Expectancy
27
Affected gene, mutation and penetrance of Myotonic dystrophy
Gene -DMPK Mutation -more than 37 CTG repeats Penetrance -need more than 50 for 100%
28
What organs are affected by myotonic dystrophy?
Skeletal Eyes Endocrine CNS
29
Mangement of Myotonic dystrophy
assistive devices (wheelchairs etc) -symptomatic treatment: -hypothyroidism, pain management arrythmia etc
30
Genetic deficit and mutated function i retinoblastoma.
Deficit Loss of function in tumor suppressor gene / RB1 Mutated function -loss of inhibiting function = uncontrolled cell cycle progression
31
Main clinical feature of Retinoblastoma
Leukocria (white pupils, clearer in photos).
32
Inheritance patterns of Retinoblastoma
Inheritance patterns: Familial or sporadic Due to loss of function on alleles on RB gene
33
Life expectancy and inheritance pattern of neurofibromatosis
Inheritance pattern Knudosons 2-hit hypothesis Lifespan -NF1= 8 years lower -NF2- normal
34
Gene locus, Clinical features and treament for NG1
Gene locus NF1 17q12 clinical features Changes in pigmentation Growth of tumors along nerves in skin/brain treatment Surgical removal of disfiguring cutaneous or sub cutaneous neurofibrils
35
Gene locus, Clinical features and treament for NG2
gene locus 22qq12.2 clinical features Growth of noncancerous tumours in nervous system = hearing loss and deafness Vestibular growth schwannomas treatment Surgical removal of vesicular schwannomas Awareness of problems with balance and underwater disorientation
36
What are the affected genes of PKD and what is the percentage contribution from each of them?
PKD1 = 85% PKD2 = 15%
37
Clinical manifestations of Polyccystic Kidney Disease.
The most common clinical presentations are hypertension, anemia, liver cysts, hematuria, flank pain, abdominal masses, urinary tract infections, renal failure, nephrolithiasis, and renal cancer
38
genetic diversity
The difference in the way that signs and symptoms of a genetic condition can show up in individual patients who have that condition